SCHEMBL9218920

SCHEMBL9218920

CCOC(=O)c1ccc(OCCC2CCN(c3nnc(Cl)c(C)c3C)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
TBXAS1 P24557 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAOA P21397 2/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 4/20 0.38
PPARG P37231 1/20 0.38
PPARD Q03181 1/20 0.38
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTT P42858 1/20 0.37
HRH2 P25021 1/20 0.37
HRH1 P35367 1/20 0.37
P2RY12 Q9H244 1/20 0.37
FDFT1 P37268 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1751840 0.85 KCNH2 (0.43) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL9212796 0.85 PIK3CA (0.44) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL15004677 0.82 KCNH2 (0.42) KCNH2HRH3TBXAS1TDP1L3MBTL1
Pirodavir SCHEMBL146440 0.80 HRH3 (0.46) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL9381746 0.78 KCNH2 (0.44) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL9381992 0.78 KCNH2 (0.50) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL9218863 0.78 HRH3 (0.44) KCNH2HRH3TBXAS1TDP1L3MBTL1
Hydrochloric Acid SCHEMBL9379751 0.78 KCNH2 (0.44) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL9379884 0.78 KCNH2 (0.44) KCNH2HRH3TBXAS1TDP1L3MBTL1
SCHEMBL9209752 0.78 HRH3 (0.44) KCNH2HRH3TBXAS1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320032-B1 Pyridizinamine derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-01-18 EP disclosed
US-5231184-A Viricide intermediate JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-27 US disclosed
US-5106973-A Viricide intermediates JANSSEN PHARMACEUTICA N.V. (BE) 1992-04-21 US disclosed
US-4992433-A Viricides JANSSEN PHARMACEUTICA N.V. (BE) 1991-02-12 US disclosed